"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Laurus Labs Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Ravindranath Kancherla
Home : Indian Private	Book Value: 97.214696
BSE Code : 540222	Market Cap: 84270.83
NSE Code : LAURUSLABS	P / E : 113.36

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	1580.30	1509.42	1566.60	1432.75
Other Income	13.09	14.37	28.45	21.52
Total Income	1593.39	1523.79	1595.05	1454.27
Total Expenditure	1204.94	1163.56	1176.94	1105.37
Operating Profit	388.45	360.23	418.11	348.90
Interest	33.91	31.48	33.68	43.89
Gross Profit	354.54	328.75	384.43	305.01
Depreciation	95.17	94.31	95.59	93.57
Tax	68.50	69.03	87.93	59.66
Deferred Tax	-0.92	-9.67	-14.76	-6.16
Reported Profit After Tax	191.79	175.08	215.67	157.94

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView